118 related articles for article (PubMed ID: 27615378)
1. Risk factors and treatment for steroid-related mood and behavior symptoms in preschool children with leukemia: A case series.
Samsel C; Muriel AC
Pediatr Blood Cancer; 2017 Feb; 64(2):343-345. PubMed ID: 27615378
[TBL] [Abstract][Full Text] [Related]
2. Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
Ularntinon S; Tzuang D; Dahl G; Shaw RJ
Pediatrics; 2010 May; 125(5):e1241-5. PubMed ID: 20385646
[TBL] [Abstract][Full Text] [Related]
3. Steroid-induced depressive psychosis responsive to electroconvulsive therapy.
Sutor B; Wells LA; Rummans TA
Convuls Ther; 1996 Jun; 12(2):104-7. PubMed ID: 8744170
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered trial.
Pound CM; Clark C; Ni A; Athale U; Lewis V; Halton JM
J Pediatr Hematol Oncol; 2012 Oct; 34(7):517-23. PubMed ID: 22735884
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for steroid-induced affective disorder in children with leukemia.
Muriel AC; Burgers DE; Treyball AN; Vrooman LM; Adolf E; Samsel C
Pediatr Blood Cancer; 2021 May; 68(5):e28847. PubMed ID: 33305874
[TBL] [Abstract][Full Text] [Related]
6. Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia.
Hochhauser CJ; Lewis M; Kamen BA; Cole PD
Support Care Cancer; 2005 Dec; 13(12):967-74. PubMed ID: 16189647
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine reduces affective instability in depressed patients with mixed mood and anxiety disorders.
Bowen RC; Balbuena L; Baetz M
J Clin Psychopharmacol; 2014 Dec; 34(6):747-9. PubMed ID: 24943394
[No Abstract] [Full Text] [Related]
8. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
[TBL] [Abstract][Full Text] [Related]
9. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
Mrakotsky CM; Silverman LB; Dahlberg SE; Alyman MC; Sands SA; Queally JT; Miller TP; Cranston A; Neuberg DS; Sallan SE; Waber DP
Pediatr Blood Cancer; 2011 Sep; 57(3):492-8. PubMed ID: 21560226
[TBL] [Abstract][Full Text] [Related]
10. Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.
Warris LT; van den Heuvel-Eibrink MM; den Hoed MA; Aarsen FK; Pieters R; van den Akker EL
Pediatr Blood Cancer; 2014 Jul; 61(7):1313-8. PubMed ID: 24532490
[TBL] [Abstract][Full Text] [Related]
11. Steroid-induced Hypertension During Induction Chemotherapy for Acute Lymphoblastic Leukemia in US Children's Hospitals.
Bakk I; Koch T; Stanek J; O'Brien SH; Reed S
J Pediatr Hematol Oncol; 2018 Jan; 40(1):27-30. PubMed ID: 29189508
[TBL] [Abstract][Full Text] [Related]
12. On the selection and use of atypical antipsychotics in the management of nonpsychotic mood and anxiety disorders.
Blier P
J Psychiatry Neurosci; 2005 Jul; 30(4):304. PubMed ID: 16049572
[No Abstract] [Full Text] [Related]
13. Psychiatric adverse effects of pediatric corticosteroid use.
Drozdowicz LB; Bostwick JM
Mayo Clin Proc; 2014 Jun; 89(6):817-34. PubMed ID: 24943696
[TBL] [Abstract][Full Text] [Related]
14. Challenges and Promises of Pediatric Psychopharmacology.
Giles LL; Martini DR
Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review.
Fardell JE; Vetsch J; Trahair T; Mateos MK; Grootenhuis MA; Touyz LM; Marshall GM; Wakefield CE
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28266135
[TBL] [Abstract][Full Text] [Related]
16. Management of anxiety and depression syndromes in the elderly.
Weiss KJ
J Clin Psychiatry; 1994 Feb; 55 Suppl():5-12. PubMed ID: 7915714
[TBL] [Abstract][Full Text] [Related]
17. Atypical uses of atypical antipsychotics.
Brooke NS; Wiersgalla M; Salzman C
Harv Rev Psychiatry; 2005; 13(6):317-39. PubMed ID: 16373327
[TBL] [Abstract][Full Text] [Related]
18. Anxiety and mood disorders in medically ill patients.
Wise MG; Taylor SE
J Clin Psychiatry; 1990 Jan; 51 Suppl():27-32. PubMed ID: 2404001
[TBL] [Abstract][Full Text] [Related]
19. Advances in treatment of mood and anxiety disorders: focus on atypical antipsychotics.
Yatham LN; Kennedy SH; Lam RW
Bipolar Disord; 2003; 5 Suppl 2():5-6. PubMed ID: 14687068
[No Abstract] [Full Text] [Related]
20. Atypical antipsychotics for mood and anxiety disorders: safe and effective adjuncts?
Blier P
J Psychiatry Neurosci; 2005 Jul; 30(4):232-3. PubMed ID: 16049565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
